| 06/04/2022 |
15:30 to 17:10 |
Plenary |
Prostate
Module - Session on High Risk and Locally Advanced Prostate Cancer |
16:45 to 17:05 |
Câncer de próstata localizado de alto risco: estado da arte e novas perspectivas |
Speaker |
| 06/04/2022 |
15:30 to 17:10 |
Plenary |
Prostate
Module - Session on High Risk and Locally Advanced Prostate Cancer |
17:05 to 17:10 |
Discussion |
Discussant |
| 06/04/2022 |
17:10 to 18:00 |
Plenary |
Clinical
cases: High Risk Prostate Cancer |
|
|
Discussant |
| 07/04/2022 |
10:05 to 10:30 |
Plenary |
Prostate
Module – Session on Recurrent Disease after Local Therapy |
10:05 to 10:25 |
Management
of castration resistant M0 disease: state of the art |
Speaker |
| 07/04/2022 |
10:05 to 10:30 |
Plenary |
Prostate
Module – Session on Recurrent Disease after Local Therapy |
10:25 to 10:30 |
Discussion |
Discussant |
| 07/04/2022 |
13:10 to 15:10 |
Plenary |
Prostate Module - Metastatic Disease Session |
13:10 to 13:25 |
Optimization
of ADT administration in advanced prostate cancer |
Speaker |
| 07/04/2022 |
13:10 to 15:10 |
Plenary |
Prostate Module - Metastatic Disease Session |
13:25 to 13:30 |
Discussion |
Discussant |
| 07/04/2022 |
13:10 to 15:10 |
Plenary |
Prostate Module - Metastatic Disease Session |
14:25 to 14:45 |
The
role and management of agents targeting androgen receptors in advanced prostate
cancer |
Speaker |
| 07/04/2022 |
13:10 to 15:10 |
Plenary |
Prostate Module - Metastatic Disease Session |
14:45 to 14:50 |
Discussion |
Discussant |
| 07/04/2022 |
17:15 to 18:10 |
Plenary |
Clinical
cases: metastatic prostate cancer |
|
|
Discussant |
